The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis
Authors:
- 15 July 2012
- journal article
- case report
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 26 (9) , 730-737
Abstract
Langerhans cell histiocytosis (LCH) has a wide spectrum of clinical manifestations, ranging from spontaneous resolution to rapid progression or death, with the risk of permanent consequences. F-18 FDG PET/CT has been used for assessment of LCH patients. However, its clinical implication has not been well elucidated, mainly due to very low incidence of LCH. The aim of this study was to evaluate the clinical usefulness of F-18 FDG PET/CT in LCH patients. A database of 12 patients (mean age 17.8 ± 17.9 years; 7 children, 5 adults) who were diagnosed histopathologically as LCH was retrospectively reviewed. Two patients underwent F-18 FDG PET/CT before and after therapy, 6 patients underwent only before therapy and 4 patients underwent only after therapy. Nine (75.0 %) and 3 patients (25.0 %) had single-system (single site and multiple sites) and multisystem involvements, respectively. Pretreatment SUVmax of patients with multisystem or multiple site involvement of a single-system was significantly higher than that of patients with single site involvement of a single-system (3.29 ± 2.52 vs. 1.63 ± 0.52, p = 0.025). One patient showed multisystem risk organs (lung and bone marrow) involvement. In 2 patients, F-18 FDG PET/CT detected additional active LCH lesions not identified on conventional imaging modalities. In follow-up F-18 FDG PET/CT scans, complete resolution was identified in 2 patients and reactivation in another 2 patients. Results of this study suggest that F-18 FDG PET/CT is useful for identification of active lesions, stratification of disease stages, monitoring of therapeutic response, and detection of reactivation in LCH patients.Keywords
This publication has 19 references indexed in Scilit:
- Endocrine manifestations of Langerhans cell histiocytosis diagnosed in adultsPituitary, 2010
- Langerhans cell histiocytosis: Current concepts and treatmentsCancer Treatment Reviews, 2010
- Primary Musculoskeletal Langerhans Cell Histiocytosis in ChildrenJournal of Pediatric Orthopaedics, 2009
- PET-CT in pediatric Langerhans cell histiocytosisPediatric Radiology, 2007
- The Nikolas Symposia and histiocytosisNature Reviews Cancer, 2005
- Predictors of outcome in children with Langerhans cell histiocytosisPediatric Blood & Cancer, 2005
- Langerhans? cell histiocytosis: pathology, imaging and treatment of skeletal involvementPediatric Radiology, 2004
- Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findingsPediatric Radiology, 2003
- LANGERHANS CELL HISTIOCYTOSIS OF LYMPH NODES: A Morphological Assessment of 43 BiopsiesPediatric Pathology & Laboratory Medicine, 1997
- HISTTOCYTOSIS SYNDROMES IN CHILDRENThe Lancet, 1987